Northeast Financial Consultants Inc / PFE
Northeast Financial Consultants Inc’s Pfizer Inc Position
Does Northeast Financial Consultants Inc own Pfizer Inc (PFE)? Yes — 1.04M shares worth $25M (+1.03% of its 13F portfolio) as of Q2 2025, down from 1.15M shares the prior filed quarter.
Position Value
$25M
Q2 2025
Shares
1.04M
% of Portfolio
+1.03%
Quarters Held
27
currently held
Position History PFE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2025 | 1.04M | $25M | +1.03% |
| Q1 2025 | 1.15M | $29M | +1.29% |
| Q4 2024 | 1.16M | $31M | +1.29% |
| Q3 2024 | 1.21M | $35M | +1.53% |
| Q2 2024 | 1.20M | $33M | +1.54% |
| Q1 2024 | 1.24M | $34M | +1.69% |
| Q4 2023 | 2.66M | $76M | +4.23% |
| Q3 2023 | 2.45M | $81M | +5.09% |
| Q2 2023 | 2.64M | $97M | +5.95% |
| Q1 2023 | 2.64M | $108M | +6.90% |
| Q4 2022 | 1.95M | $100M | +6.74% |
| Q3 2022 | 1.90M | $83M | +6.10% |
| Q2 2022 | 1.96M | $103M | +7.16% |
| Q1 2022 | 1.97M | $102M | +5.91% |
| Q4 2021 | 1.59M | $94M | +5.66% |
| Q3 2021 | 1.60M | $69M | +4.60% |
| Q2 2021 | 1.61M | $63M | +4.24% |
| Q1 2021 | 1.30M | $47M | +3.60% |
| Q4 2020 | 1.29M | $48M | +3.94% |
| Q3 2020 | 2.83M | $104M | +9.39% |
| Q2 2020 | 2.77M | $92M | +8.79% |
| Q1 2020 | 2.75M | $90M | +10.17% |
| Q4 2019 | 2.42M | $95M | +8.48% |
| Q3 2019 | 1.62M | $58M | +5.93% |
| Q2 2019 | 2.40M | $104M | +10.65% |
| Q1 2019 | 2.39M | $102M | +11.29% |
| Q4 2018 | 2.42M | $105M | +14.68% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Northeast Financial Consultants Inc’s full portfolio or all institutional holders of PFE.